December 20, 2016
The Japan arm of AstraZeneca said on December 19 that it has sealed a collaborative accord with the National Cancer Center (NCC) on exploratory biomarker research for immuno-oncology therapies targeting lung cancer. The new collaboration comes as an extension of...read more